| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
2 companies
Pura Vida Investments, LLC last filed a Form 4 in April 2023, as 10% Owner at IMDX. The filings on record cover 2 companies.
Our model assigns Pura Vida Investments, LLC a below-average insider score of 31/100, based on 3 past trades. Over a 12-month horizon, 33.3% of those trades were profitable, with an average 12-month return of -13.3%.
At the last filing, the largest reported position was 8,090,202 shares of IMDX. Net of sales, the IMDX filings show accumulation of 6,495,321 shares.
Pura Vida Investments, LLC has 8 Form 4 filings on record from September 2019 to April 2023, across 2 companies: 10% Owner at Insight Molecular Diagnostics (IMDX), 2022–2023; 10% Owner at Greenlane (GNLN), 2019.
The 27 reported transactions were 19 open-market purchases, 7 open-market sales and 1 other transaction.
Counted by filing, the open-market trades come to 5 purchases worth about $8.9M and 3 sales worth about $779K.
The largest open-market purchase was 5,931,707 shares of IMDX at an average $1.33 on April 14, 2022, about $7.9M. Twelve months later IMDX was down 75%.
The largest open-market sale was 150,000 shares of GNLN at an average $3.08 on December 5, 2019, about $462K.
Shares as reported in the last Form 4 for each company; the most recent is from April 2023. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 5, 2023 | IMDX Insight Molecular Diagnostics Inc. | 10% Owner | Buy | 663,000 | $0.30 | $200,027.10 | +8.9% | -17.7% | -45.6% | |
| Jun 24, 2022 | IMDX Insight Molecular Diagnostics Inc. | 10% Owner | Sell | 99,386 | $1.03 | $102,634.77 | -1.2% | -21.9% | -80.4% | |
| Apr 14, 2022 | IMDX Insight Molecular Diagnostics Inc. | 10% Owner | Buy | 5,931,707 | $1.33 | $7,887,849.58 | -130.4% | -27.8% | -74.7% | |
| Dec 9, 2019 | GNLN Greenlane Holdings, Inc. | 10% Owner | Sell | 75,000 | $2.86 | $214,500.00 | -7.0% | - | - | |
| Dec 5, 2019 | GNLN Greenlane Holdings, Inc. | 10% Owner | Sell | 150,000 | $3.08 | $462,000.00 | -11.6% | - | - | |
| Dec 5, 2019 | GNLN Greenlane Holdings, Inc. | 10% Owner | Buy | 150,000 | $3.10 | $464,250.00 | +14.0% | - | - | |
| Sep 30, 2019 | GNLN Greenlane Holdings, Inc. | 10% Owner | Buy | 10,000 | $3.39 | $33,900.00 | +0.8% | - | - | |
| Sep 24, 2019 | GNLN Greenlane Holdings, Inc. | 10% Owner | Buy | 75,000 | $4.25 | $318,950.00 | -150.0% | - | - |